Ultravist - Iopromide 370 mg / mL Injection 200 mL

NDC 50419-0346-20 is also written 50419034620, or 50419-346-20 (5041934620) in 10-digit form. Reference details for licensed healthcare facility review and verification.

NDC 1150419-0346-20
Product NDC50419-0346
Generic Drug Nameiopromide
Brand NameUltravist
ManufacturerBayer HealthCare Pharmaceuticals Inc.
Strength370 mg / mL
Dosage FormInjection
Drug TypeIntra-Arterial; Intravenous
Package Quantity10 Vial, Glass
Package Description10 VIAL, GLASS in 1 CARTON (50419-346-20) / 200 mL in 1 VIAL, GLASS
Active IngredientsIopromide
Marketing CategoryNDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

iopromide 370 mg / mL Injection is tracked under NDC 50419-0346-20 and rolls up into product family 50419-0346. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 10 Vial, Glass.
  • Manufacturer: Bayer HealthCare Pharmaceuticals Inc..
  • Dosage form: Injection.
  • Family size: 10 indexed presentations.

Click a tag to refine the catalog view around this product reference.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Alternate presentations in this family

These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Potential alternatives with matching presentation

Open the comparison hub or review package-level listings from 2 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.

View Potential Alternative Hubiopromide 370 mg / mL Injection 200 mL Vial3 package-level listings in the comparison hub.

Sample package-level pages in this comparison set

Drug Shortage Information

Shortage summary

Public sources include shortage-history links for Ultravist (iopromide) centered on the 2022 iodinated contrast media shortage and FDA-authorized foreign-labeled supply.

This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.

Ultravist - Iopromide 370 mg / mL Injection 200 mL, NDC 50419-0346-20, is a Bayer HealthCare Pharmaceuticals Inc. 370 mg / mL injection presentation packaged as 10 Vial, Glass. Historical public shortage information is available for this product reference.

NDC search formats

  • Canonical NDC 11: 50419-0346-20
  • Digits-only NDC 11: 50419034620
  • Possible 10-digit display format: 50419-346-20 (5041934620)

Helpful product links